ChEBI
polyunsaturated fatty acyl-CoA(4-)
- Term ID
-
CHEBI:77330
- Synonyms
-
- polyunsaturated fatty acyl-CoA
- PUFA-CoA(4-)
- Definition
-
An acyl-CoA oxoanion arising from deprotonation of the phosphate and diphosphate OH groups of any acyl-CoA where the fatty acyl chain contains 2 or more carbon to carbon double bonds; major species at pH 7.3.
- References
-
- Ontology
-
ChEBI
(
EBI
)
Relationships
- is a type of
-
- has subtype
-
(2E,4E)-tetradecadienoyl-CoA(4-)
(2E,4E,8Z,11Z,14Z)-icosapentaenoyl-CoA(4-)
(2E,4Z)-deca-2,4-dienoyl-CoA(4-)
(2E,5E)-tetradecadienoyl-CoA(4-)
(2E,5Z)-octadienoyl-CoA(4-)
(2E,7Z)-hexadecadienoyl-CoA(4-)
(2E,9Z)-hexadecadienoyl-CoA(4-)
(3E,5Z)-dodecadienoyl-CoA(4-)
(3E,5Z)-tetradecadienoyl-CoA(4-)
(3E,5Z,8Z,11Z,14Z)-icosapentaenoyl-CoA(4-)
(3Z,5E)-dodecadienoyl-CoA(4-)
(3Z,6Z)-dodecadienoyl-CoA(4-)
(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl-CoA(4-)
(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-CoA(4-)
(5Z,8Z,11Z,14Z,17Z)-icosapentaenoyl-CoA(4-)
(5Z,11Z,14Z)-icosatrienoyl-CoA(4-)
(5Z,11Z,14Z,17Z)-icosatetraenoyl-CoA(4-)
(6Z,9Z,12Z,15Z)-octadecatetraenoyl-CoA(4-)
(6Z,9Z,12Z,15Z,18Z)-tetracosapentaenoyl-CoA(4-)
(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosahexaenoyl-CoA(4-)
(7Z,10Z,13Z)-hexadecatrienoyl-CoA(4-)
(7Z,10Z,13Z,16Z)-docosatetraenoyl-CoA(4-)
(7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl-CoA(4-)
(8Z,11Z)-icosadienoyl-CoA(4-)
(8Z,11Z,14Z)-icosatrienoyl-CoA(4-)
(8Z,11Z,14Z,17Z)-icosatetraenoyl-CoA(4-)
(8Z,11Z,14Z,17Z,20Z)-hexacosapentaenoyl-CoA(4-)
(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosahexaenoyl-CoA(4-)
(9Z,12Z)-18-hydroxyoctadecadienoyl-CoA(4-)
(9Z,12Z)-heptadecadienoyl-CoA(4-)
(9Z,12Z)-hexadeca-9,12,15-trienoyl-CoA(4-)
(9Z,12Z)-hexadecadienoyl-CoA(4-)
(9Z,12Z)-pentadecadienoyl-CoA(4-)
(9Z,12Z)-tetradecadienoyl-CoA(4-)
(9Z,12Z,15Z,18Z)-tetracosatetraenoyl-CoA(4-)
(9Z,12Z,15Z,18Z,21Z)-tetracosapentaenoyl-CoA(4-)
(10E,12Z)-hexadecadienoyl-CoA(4-)
(10Z,13Z,16Z)-docosatrienoyl-CoA(4-)
(10Z,13Z,16Z,19Z)-docosatetraenoyl-CoA(4-)
(10Z,13Z,16Z,19Z,22Z)-octacosapentaenoyl-CoA(4-)
(10Z,13Z,16Z,19Z,22Z,25Z)-octacosahexaenoyl-CoA(4-)
(11Z,14Z)-icosadienoyl-CoA(4-)
(11Z,14Z,17Z)-icosatrienoyl-CoA(4-)
(11Z,14Z,17Z,20Z)-hexacosatetraenoyl-CoA(4-)
(11Z,14Z,17Z,20Z,23Z)-hexacosapentaenoyl-CoA(4-)
(12Z,15Z,18Z,21Z)-tetracosatetraenoyl-CoA(4-)
(12Z,15Z,18Z,21Z,24Z)-triacontapentaenoyl-CoA(4-)
(12Z,15Z,18Z,21Z,24Z,27Z)-triacontahexaenoyl-CoA(4-)
(13Z,16Z,19Z,22Z)-octacosatetraenoyl-CoA(4-)
(13Z,16Z,19Z,22Z,25Z)-octacosapentaenoyl-CoA(4-)
(14Z,17Z,20Z,23Z,26Z)-dotriacontapentaenoyl-CoA(4-)
(14Z,17Z,20Z,23Z,26Z,29Z)-dotriacontahexaenoyl-CoA(4-)
(15Z,18Z,21Z,24Z)-triacontatetraenoyl-CoA(4-)
(15Z,18Z,21Z,24Z,27Z)-triacontapentaenoyl-CoA(4-)
(16Z,19Z,22Z,25Z,28Z)-tetratriacontapentaenoyl-CoA(4-)
(16Z,19Z,22Z,25Z,28Z,31Z)-tetratriacontahexaenoyl-CoA(4-)
(17Z,20Z,23Z,26Z)-dotriacontatetraenoyl-CoA(4-)
(17Z,20Z,23Z,26Z,29Z)-dotriacontapentaenoyl-CoA(4-)
(18Z,21Z,24Z,27Z,30Z)-hexatriacontapentaenoyl-CoA(4-)
(18Z,21Z,24Z,27Z,30Z,33Z)-hexatriacontahexaenoyl-CoA(4-)
(19Z,22Z,25Z,28Z)-tetratriacontatetraenoyl-CoA(4-)
(19Z,22Z,25Z,28Z,31Z)-tetratriacontapentaenoyl-CoA(4-)
(20Z,23Z,26Z,29Z,32Z)-octatriacontapentaenoyl-CoA(4-)
(21Z,24Z,27Z,30Z)-hexatriacontatetraenoyl-CoA(4-)
(21Z,24Z,27Z,30Z,33Z)-hexatriacontapentaenoyl-CoA(4-)
(23Z,26Z,29Z,32Z)-octatriacontatetraenoyl-CoA(4-)
(23Z,26Z,29Z,32Z,35Z)-octatriacontapentaenoyl-CoA(4-)
5,6-epoxy-(8Z,11Z,14Z)-icosatrienoyl-CoA(4-)
5-hydroxy-(6E,8Z,11Z,14Z)-icosatetraenoyl-CoA(4-)
8,9-epoxy-(5Z,11Z,14Z)-icosatrienoyl-CoA(4-)
11,12-epoxy-(5Z,8Z,14Z)-icosatrienoyl-CoA(4-)
11-oxo-ETE-CoA(4-)
12-hydroxy-(5Z,8Z,10E,14Z)-icosatetraenoyl-CoA(4-)
14,15-epoxy-(5Z,8Z,11Z)-icosatrienoyl-CoA(4-)
15-hydroxy-(5Z,8Z,11Z,13E)-icosatetraenoyl-CoA(4-)
15-oxo-ETE-CoA(4-)
arachidonoyl-CoA(4-)
docosahexaenoyl-CoA(4-)
octadecadienoyl-CoA(4-)
octadecatrienoyl-CoA(4-)
omega-3 unsaturated fatty acyl-CoA(4-)
oxidized eicosatetraenoyl-CoA(4-)
oxidized icosatrienoyl-CoA(4-)
Show first 5 Terms
Phenotype
Phenotype resulting from polyunsaturated fatty acyl-CoA(4-)
Phenotype where environments contain polyunsaturated fatty acyl-CoA(4-)
Phenotype modified by environments containing polyunsaturated fatty acyl-CoA(4-)
Human Disease / Model Data